Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
- PMID: 40699863
- PMCID: PMC12191510
- DOI: 10.3390/cimb47060464
Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
Abstract
Reactive oxygen species (ROS) are central to the progression of alcoholic fatty liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD). In ALD, ROS arise from alcohol metabolism (CYP2E1 and ADH/ALDH2), causing oxidative damage and fibrosis. In NAFLD, mitochondrial dysfunction, ER stress, and lipotoxicity drive ROS overproduction due to metabolic dysregulation. Both diseases share ROS-mediated pathways, including mitochondrial/ER dysfunction, inflammation, and impaired lipid metabolism, accelerating steatosis to cirrhosis and cancer. Antioxidants, ER modulators, and lifestyle changes show therapeutic potential but require further clinical validation. Future research should leverage multi-omics and targeted therapies to optimize ROS-focused interventions for ALD and NAFLD.
Keywords: alcoholic fatty liver disease; nonalcoholic fatty liver disease; reactive oxygen species.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.J Ethnopharmacol. 2022 Jun 28;292:115146. doi: 10.1016/j.jep.2022.115146. Epub 2022 Mar 16. J Ethnopharmacol. 2022. PMID: 35304272
-
Combating oxidative stress in non-alcoholic fatty liver disease: From mechanisms to therapeutic strategies.Pathol Res Pract. 2025 Aug;272:156053. doi: 10.1016/j.prp.2025.156053. Epub 2025 May 30. Pathol Res Pract. 2025. PMID: 40466577 Review.
-
Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions.Medicina (Kaunas). 2021 Aug 14;57(8):822. doi: 10.3390/medicina57080822. Medicina (Kaunas). 2021. PMID: 34441028 Free PMC article.
-
Fungal signature differentiates alcohol-associated liver disease from nonalcoholic fatty liver disease.Gut Microbes. 2024 Jan-Dec;16(1):2307586. doi: 10.1080/19490976.2024.2307586. Epub 2024 Feb 1. Gut Microbes. 2024. PMID: 38298161 Free PMC article.
-
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261. Nutrients. 2022. PMID: 36558421 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous